12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant movements. First Wave BioPharma, Cingulate, NKGen Biotech, Cytokinetics, Coherus BioSciences, and Opthea saw their stocks rise by 119.2%, 83.83%, 51.41%, 43.29%, 41.28%, and 25.0% respectively. Conversely, Iovance Biotherapeutics, IMAC Holdings, Biophytis, SINTX Techs, Yield10 Bioscience, and Onconetix experienced declines in their stock prices.
December 27, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IMAC Holdings' shares decreased by 13.96% to $2.96, with a market cap of $3.3 million.
IMAC Holdings' stock decline suggests potential negative factors at play, which may result in further short-term depreciation.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Biophytis' stock fell by 9.88% to $0.72, with a market cap of $7.0 million.
The pre-market drop in BPTS stock could indicate investor concerns, potentially leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 55
RELEVANCE 100
NEGATIVE IMPACT
Iovance Biotherapeutics' stock dropped 26.3% to $6.55, with a market cap of $1.6 billion.
The significant pre-market decline for IOVA could reflect negative sentiment or news, likely leading to a short-term downtrend.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Onconetix's shares fell 8.43% to $0.19, with a market cap of $3.6 million.
Onconetix's stock price drop suggests a bearish outlook, which may persist in the short term.
CONFIDENCE 85
IMPORTANCE 40
RELEVANCE 100
NEGATIVE IMPACT
SINTX Techs' stock declined by 9.18% to $0.43, with a market value of $1.8 million.
SINTX Techs' stock decrease may reflect negative market sentiment, suggesting a possible continuation of the downtrend in the short term.
CONFIDENCE 85
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Yield10 Bioscience's shares fell 8.55% to $0.2, with a market value of $2.4 million.
The decline in YTEN shares could signal underlying issues, potentially leading to further short-term negative performance.
CONFIDENCE 85
IMPORTANCE 45
RELEVANCE 100
POSITIVE IMPACT
Coherus BioSciences' shares increased by 41.28% to $3.08, with a market cap of $343.0 million.
The surge in CHRS stock suggests positive developments that could lead to further short-term price increases.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Cingulate's stock increased by 83.83% to $3.64, with a market cap of $3.4 million.
Cingulate's significant pre-market rise suggests positive investor sentiment, which may result in continued short-term price appreciation.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Cytokinetics' stock went up by 43.29% to $65.5, with a market cap of $6.4 billion.
Cytokinetics' notable pre-market increase may attract more investors, potentially driving the stock higher in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
First Wave BioPharma's stock soared 119.2% to $8.09 with a market cap of $5.4 million.
The substantial pre-market gain for FWBI indicates strong investor interest, likely due to positive news or expectations, which could lead to a short-term uptrend.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
NKGen Biotech's stock rose by 51.41% to $4.27, with a market cap of $93.4 million.
The sharp increase in NKGN's stock price could indicate market optimism, potentially leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Opthea's shares rose by 25.0% to $3.15, with a market value of $260.9 million.
Opthea's stock rise indicates investor confidence, which may continue to push the stock up in the short term.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100